Biophytis Targets Mobility Restoration in Patients with Obesity @biophytis #biotech #GLP1 #muscle #obesity #weightloss #Chemicals #Biotechnology #OTC #OTCMarkets #OTCStocks #Investing
Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - April 22, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in developing treatments for age-related diseases strentghens its position as one of the leading players in preserving muscle function in patients with obesity treated with GLP-1 therapies. While these treatments are revolutionizing obesity care by delivering significant weight loss, they also induce a...
http://dlvr.it/TKHyMR
http://dlvr.it/TKHyMR
Comments
Post a Comment